| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/19/2006 | EP0898580B1 Methods and means for inhibition of cdk4 activity |
| 07/19/2006 | EP0831923B1 Separation of active complexes |
| 07/19/2006 | CN1804042A Promotion of nerve cell differentiation by human14-3-3 yupsilon protein |
| 07/19/2006 | CN1804041A Human decorin-expressing recombined adeno-associated virus and preparation method thereof |
| 07/19/2006 | CN1804038A VEGF expression-inhibiting siRNA and application thereof |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803832A 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 07/19/2006 | CN1803823A SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application |
| 07/19/2006 | CN1803195A Immunity regulating type Eimeria tenella DNA vaccine for preventing and treating chicken coccidiosis |
| 07/19/2006 | CN1803194A Immunity regulating type DNA vaccine for preventing and treating chicken coccidiosis |
| 07/19/2006 | CN1264980C Novel tumor antigen protein SART-3 and tumor antigen peptide thereof |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264572C Fusion protein for treating HBV and its uses |
| 07/19/2006 | CN1264570C Therapeutic use of growth factor VEGF in preparing medicine for preventing and treating endangium hyperplasia |
| 07/19/2006 | CN1264568C Virulence genes and proteins, and their use |
| 07/18/2006 | US7078516 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078513 plasmid is a viral or bacterial expression vector and is expressed in a prokaryotic or eukaryotic cell; gene therapy and immunotherapy; prenatal screening and diagnosis |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078389 Hybridization of a mutagen substituted single-strand nucleic acid molecule with DNA causes a mutation at a specific site; antiproliferative and anticarcinogenic agents; gene therapy |
| 07/18/2006 | US7078388 DNA vaccines for farm animals, in particular bovines and porcines |
| 07/18/2006 | US7078231 Human pancreatic progenitor cells for use in cell therapy |
| 07/18/2006 | US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell |
| 07/18/2006 | US7078218 replicon RNAs are electroporated into permissive cells and are harvested from the surfaces of the cells using a salt wash in which the salt concentration is from about 0.2 to about 5 M sodium/calcium/magnesium/potassium chloride |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078205 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078191 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078180 Based on alterations in ZEB expression levels and subcellular localization. |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078043 Malaria vaccine |
| 07/18/2006 | US7078032 Delivery of therapeutic biologicals from implantable tissue matrices |
| 07/18/2006 | US7078031 delivering genes; gag genes, gag protein; endothelial growth factor |
| 07/18/2006 | US7078030 Oncolytic adenovirus |
| 07/18/2006 | US7078029 Having a genome with a mutation of a TAATGARAT sequence such that, in the presence of a ICP4 gene product, a native immediate early gene is expressed from the genome with delayed kinetics |
| 07/18/2006 | US7078028 Anti-neoplastic viral agents |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/13/2006 | WO2006074452A2 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases |
| 07/13/2006 | WO2006074346A2 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 07/13/2006 | WO2006074182A2 Growth factor therapy mobilization of stem cells into the peripheral blood |
| 07/13/2006 | WO2006074108A2 Compositions and methods for modulating gene expression using self-protected oligonucleotides |
| 07/13/2006 | WO2006073970A2 Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
| 07/13/2006 | WO2006073760A2 Regulation of mink in thymocytes and t lymphocytes |
| 07/13/2006 | WO2006073625A2 Inhibition of li expression in mammalian cells |
| 07/13/2006 | WO2006073602A2 Rnai modulation of the bcr-abl fusion gene and uses thereof |
| 07/13/2006 | WO2006073601A2 Methods and compositions for rna interference |
| 07/13/2006 | WO2006073183A1 Method of judging inflammatory disease by using single nucleotdie polymorphism |
| 07/13/2006 | WO2006072809A2 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions |
| 07/13/2006 | WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof |
| 07/13/2006 | WO2006020889A3 Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| 07/13/2006 | WO2005117974B1 Cancer treatment method by inhibiting mage gene expression or function |
| 07/13/2006 | WO2005109001A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 07/13/2006 | US20060155111 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 07/13/2006 | US20060154890 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 07/13/2006 | US20060154889 Polyfluorinated nucleoside analogs and methods of use thereof |
| 07/13/2006 | US20060154888 LNA oligonucleotides and the treatment of cancer |
| 07/13/2006 | US20060154887 Use of apoptosis-specific eIF-5A siRNAs and antisense polynucleotides to inhibit/suppress an inflammatory response |
| 07/13/2006 | US20060154886 Regulatory elements in the 5' region of the VR1 gene |
| 07/13/2006 | US20060154885 NUCLEOTIDE SEQUENCES FOR USE IN THE TREATMENT OF BONE DISORDERS, chondrodysplasia; BIODRUG, MODIFIED NUCLEOTIDES |
| 07/13/2006 | US20060154884 Use of a vegf receptor gener or gene product |
| 07/13/2006 | US20060154883 Nonsense-mediated mrna decay |
| 07/13/2006 | US20060154882 Methods for blocking adipocyte differentiation and triglyceride accumulation with g-alpha-i3 inhibitors |
| 07/13/2006 | US20060154870 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 07/13/2006 | US20060154867 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 07/13/2006 | US20060154860 Manipulating stem-progenitor cell trafficking to injured tissue and/or tumors by altering HIF-1 and/or SDF-1 activity |
| 07/13/2006 | US20060154856 NADPH oxidase inhibition pharmacotherapies for Obstructive Sleep Apnea syndrome and its associated morbidities |
| 07/13/2006 | US20060154330 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 07/13/2006 | US20060154295 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060154291 Reagents and methods useful for detecting diseases of the breast |
| 07/13/2006 | US20060154285 Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2) |
| 07/13/2006 | US20060154271 Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR |
| 07/13/2006 | US20060154262 Identification of genes involved in metastatic progression of cancer cells |
| 07/13/2006 | US20060153921 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions |
| 07/13/2006 | US20060153883 HM1.24-utilizing cancer vaccines |
| 07/13/2006 | US20060153880 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 07/13/2006 | US20060153879 Streptococcal C5a peptidase vaccine |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153874 Recombinant poxvirus comprising at least two compox ati promoters |
| 07/13/2006 | US20060153870 Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153847 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc |
| 07/13/2006 | US20060153844 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153826 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153821 Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products |
| 07/13/2006 | US20060153820 Materials and methods relating to the production and maintenance of cell lines |
| 07/13/2006 | US20060153810 Process for preparing retrovirus vector for gene therapy |
| 07/13/2006 | US20060153809 Recombinant trail vectors and uses thereof |
| 07/13/2006 | US20060153808 Cancer immunotherapy incorporating p53 |
| 07/13/2006 | US20060153807 Vector-mediated gene regulation in midbrain dopamine neurons |
| 07/13/2006 | US20060153806 Proteins involved in the regulation of energy homeostasis |
| 07/13/2006 | US20060153805 Viral vectors and the use of the same for gene therapy |
| 07/13/2006 | US20060153804 Nucleic acid coated particles |
| 07/13/2006 | US20060153800 DNA immunization with recombinase/transposase |
| 07/13/2006 | DE10057014B4 Verfahren zur Herstellung von zielzellspezifischen Arzneimitteln Process for the preparation of target cell-specific drugs |
| 07/13/2006 | CA2594040A1 Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |